Jupiter Life Line Hospitals Limited — PPTs, 07-02-2025: Investor Presentation

**Financial Highlights:** Jupiter Life Line Hospitals reported a strong performance for the nine months of FY25, with total income reaching ₹934.8 Cr, showcasing a year-on-year growth of 19.5%. EBITDA improved to ₹218.3 Cr, reflecting a 22.0% increase, while PAT rose to ₹148.6 Cr, up 13.2% year-on-year.

**Strategic Initiatives and Growth Drivers:** The company has acquired approximately 2 acres of land in Mira-Bhayandar for its sixth hospital, aiming for a capacity of 300 beds with a capital expenditure of ₹400 Cr. Construction for the second Pune hospital is set to begin in March 2025, following the approval of requisite regulatory clearances.

**Business Developments:** Jupiter has successfully expanded its Indore hospital's capacity by adding 78 beds ahead of schedule, resulting in a total of 309 beds. The Dombivli hospital is on track for a phased opening, with Phase 1 expected by Q1 FY27.

**Market Position and Competitive Advantage:** The company is capitalizing on growth opportunities, particularly in the Western region, with ongoing efforts to establish a network of 2,500 beds across their facilities.

**Investor Implications:** With robust financial growth and strategic expansions, Jupiter Life Line Hospitals presents a favorable outlook for investors, highlighting its commitment to quality healthcare and operational excellence.